Pregabalin Capsule
Product Images NDC 71335-1745

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351745)

This is a packaging label for a medication named "Compare To" packed by Bryant Ranck Prepack. It is available in the form of capsules. The label also provides information related to the comparison of the medication with Lyrica 150mg (CV) capsule produced by Alkem Laboratories Limited. The medication should be stored at a temperature between 20°C-25°C (68°F-77°F) and must be kept out of the reach of children. The NDC number provided is 7133517451, and the label also has a product code of 08198301523487.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This text appears to be a formula or equation and lacks context or additional information to generate a meaningful description. Therefore, the description is not-available.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This appears to be a chart or a table, showing the results from two clinical studies labeled Study E1 and Study E3 with different dosages of a drug (ranging from 50mg/day to 600mg/day) and a placebo group. The percentage changes in some outcome measures are presented, with some marked as "statistically significant vs placebo". There is not enough context or information to determine what the drug does, what outcome measures were evaluated, or any other details about the study.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

The text is describing the improvement of patients and their pain management. It mentions the use of two dosages of Pregabalin, one at 200mg three times a day and the other at 100mg three times a day, along with a placebo. There is a measurement of a percentage improvement in pain levels from a baseline. However, the presence of the random string of characters makes the text appear incomplete and difficult to read.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This is a table showing the percent improvement in pain from baseline for different doses of Pregabalin. It appears that the 450mg daily dose has the highest percent improvement at 100%.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.